Developing high-performance algal strains to power a sustainable blue bioeconomy.
Algae naturally produce high-value compounds (e.g., pigments, lipids), but often at low productivities. We use random mutagenesis and targeted screening to obtain hyper-producers or mutants with superior operational traits (e.g., increased resistance to abiotic factors and growth). This translates scientific potential into scalable, industrial profitability.
Our advanced Flow Cytometry platform allows for the rapid analysis of phenotypic changes. This high-throughput capability is crucial for quickly and precisely detecting superior mutants within large populations, accelerating our development cycle and ensuring the selection of the best-performing strains.
We maintain an extensive Mutant Bank of strains generated exclusively through random mutagenesis. This diverse bank is a proprietary asset that reduces project timelines, providing a head start in the search for your ideal industrial strain without the typical regulatory constraints of genetic engineering.
Our team, including Daniel Figueiredo, Ricardo Francisco, Inês Trincheiras, Pedro Moñino, and Professor João Varela, offers a unique blend of expertise. We bring deep knowledge in classical mutagenesis, targeted screening, and process optimization, ensuring a holistic approach to every challenge.
We provide contract research and consultancy services to drive your project from concept to commercial viability. Our services include parental species selection and evaluation, random mutagenesis, adaptive laboratory evolution, targeted screening and phenotypic validation.
Our lab is fully equipped for scalable strain development, from cultivation in well plates to optimization in benchtop bioreactors. We have an in-house Flow Cytometer with spectral technology for rapid analysis and access to FACS for advanced screening and isolation. We are proficient in cultivating strains under all trophic conditions, offering maximum flexibility for diverse industrial applications. We also maintain an extensive library of mutagenic and screening agents.
We develop cutting-edge prototypes that transform innovation and scientific advances into tangible, real-world solutions
